These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 32304786)

  • 1. HPV16 L1 diversity and its potential impact on the vaccination-induced immunity.
    El Aliani A; El Abid H; Kassal Y; Khyatti M; Attaleb M; Ennaji MM; El Mzibri M
    Gene; 2020 Jul; 747():144682. PubMed ID: 32304786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Worldwide genetic variations in high-risk human papillomaviruses capsid L1 gene and their impact on vaccine efficiency.
    Oumeslakht L; Ababou M; Badaoui B; Qmichou Z
    Gene; 2021 May; 782():145533. PubMed ID: 33636291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation Profile of HPV16 L1 and L2 Genes in Different Geographic Areas.
    Tsakogiannis D; Nikolaidis M; Zagouri F; Zografos E; Kottaridi C; Kyriakopoulou Z; Tzioga L; Markoulatos P; Amoutzias GD; Bletsa G
    Viruses; 2022 Dec; 15(1):. PubMed ID: 36680181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of Surface-Exposed Loops on the HPV16 Capsid to Antigenic Domains Recognized by Vaccine or Natural Infection Induced Neutralizing Antibodies.
    Godi A; Vaghadia S; Cocuzza C; Miller E; Beddows S
    Microbiol Spectr; 2022 Jun; 10(3):e0077922. PubMed ID: 35475682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of major capsid protein (L1) variants of Human papillomavirus type 16 by cervical neoplastic status in Indian women: Phylogenetic and functional analysis.
    Mane A; Patil L; Limaye S; Nirmalkar A; Kulkarni-Kale U
    J Med Virol; 2020 Aug; 92(8):1303-1308. PubMed ID: 31944308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus type 16 pseudovirions with few point mutations in L1 major capsid protein FG loop could escape actual or future vaccination for potential use in gene therapy.
    Fleury MJ; Touzé A; Coursaget P
    Mol Biotechnol; 2014 May; 56(5):479-86. PubMed ID: 24639327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the diversity of human papillomavirus 16 variants and L1 antigenic regions relevant for the prevention of human papillomavirus-related oropharyngeal cancer in Japan.
    Yoshida T; Ogawa T; Nakanome A; Ohkoshi A; Ishii R; Higashi K; Ishikawa T; Katori Y; Furukawa T
    Auris Nasus Larynx; 2022 Dec; 49(6):1033-1041. PubMed ID: 35491282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino acid sequence diversity of the major human papillomavirus capsid protein: implications for current and next generation vaccines.
    Ahmed AI; Bissett SL; Beddows S
    Infect Genet Evol; 2013 Aug; 18():151-9. PubMed ID: 23722024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer.
    Yang R; Wheeler CM; Chen X; Uematsu S; Takeda K; Akira S; Pastrana DV; Viscidi RP; Roden RB
    J Virol; 2005 Jun; 79(11):6741-50. PubMed ID: 15890912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Diversity in the Major Capsid L1 Protein of HPV-16 and HPV-18 in the Netherlands.
    King AJ; Sonsma JA; Vriend HJ; van der Sande MA; Feltkamp MC; Boot HJ; Koopmans MP;
    PLoS One; 2016; 11(4):e0152782. PubMed ID: 27070907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capsid display of a conserved human papillomavirus L2 peptide in the adenovirus 5 hexon protein: a candidate prophylactic hpv vaccine approach.
    Wu WH; Alkutkar T; Karanam B; Roden RB; Ketner G; Ibeanu OA
    Virol J; 2015 Sep; 12():140. PubMed ID: 26362430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variability in the major capsid L1 protein of human papillomavirus type 16 (HPV-16) and 18 (HPV-18).
    Frati E; Bianchi S; Colzani D; Zappa A; Orlando G; Tanzi E
    Infect Genet Evol; 2011 Dec; 11(8):2119-24. PubMed ID: 21729769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The U4 Antibody Epitope on Human Papillomavirus 16 Identified by Cryo-electron Microscopy.
    Guan J; Bywaters SM; Brendle SA; Lee H; Ashley RE; Christensen ND; Hafenstein S
    J Virol; 2015 Dec; 89(23):12108-17. PubMed ID: 26401038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination of healthy volunteers with human papillomavirus type 16 L2E7E6 fusion protein induces serum antibody that neutralizes across papillomavirus species.
    Gambhira R; Gravitt PE; Bossis I; Stern PL; Viscidi RP; Roden RB
    Cancer Res; 2006 Dec; 66(23):11120-4. PubMed ID: 17145854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Production of human papillomavirus type 16 virus-like particles and its immunogenicity].
    Wei MX; Li SW; Huang B; Shen WT; Su YZ; Zhang CH; Gu Y; Du HL; Zhang J; Xia NS
    Bing Du Xue Bao; 2009 Jul; 25(4):245-50. PubMed ID: 19769155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developments in L2-based human papillomavirus (HPV) vaccines.
    Schellenbacher C; Roden RBS; Kirnbauer R
    Virus Res; 2017 Mar; 231():166-175. PubMed ID: 27889616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of mucosal and systemic immune responses following oral immunization of mice with Lactococcus lactis expressing human papillomavirus type 16 L1.
    Cho HJ; Shin HJ; Han IK; Jung WW; Kim YB; Sul D; Oh YK
    Vaccine; 2007 Nov; 25(47):8049-57. PubMed ID: 17936447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.
    Fraillery D; Baud D; Pang SY; Schiller J; Bobst M; Zosso N; Ponci F; Nardelli-Haefliger D
    Clin Vaccine Immunol; 2007 Oct; 14(10):1285-95. PubMed ID: 17687110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variability of human papillomavirus type 66 L1 gene among women presenting for cervical cancer screening in Chile.
    Balanda M; Fernández J; Vergara N; Campano C; Arata L; Martín HS; Ramírez E
    Med Microbiol Immunol; 2019 Dec; 208(6):757-771. PubMed ID: 31165237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved efficiency of a Salmonella-based vaccine against human papillomavirus type 16 virus-like particles achieved by using a codon-optimized version of L1.
    Baud D; Ponci F; Bobst M; De Grandi P; Nardelli-Haefliger D
    J Virol; 2004 Dec; 78(23):12901-9. PubMed ID: 15542642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.